BOLD — Audentes Therapeutics, Inc.

Ownership history in BB BIOTECH AG  ·  2 quarters on record

This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Audentes Therapeutics, Inc. (BOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.34% (2019 Q1)
Avg. % of fund
0.93%
First filed
2018 Q4
Last filed
2019 Q1
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2019 Q1 ADDED 1,369,604 +600,200 +78.0% 1.34% $53.4M —
2018 Q4 INITIATED 769,404 — — 0.53% $16.4M —
% of Fund (quarterly)    BOLD price (monthly, adj. close)

Other funds also holding BOLD

As of 2025 Q4 — sorted by position size

SECTORAL ASSET MANAGEMENT INC 3Y 7Y 0.65% Stonepine Capital Management, LLC 3Y 7Y 0.62% Sio Capital Management, LLC 3Y 7Y 0.03% RBF Capital, LLC 3Y 7Y 0.01% LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.01% Nolet Wealth Management, LLC 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% Abel Hall, LLC 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0%
← Back to BB BIOTECH AG Holdings